Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Apr 13, 2010


DNAnexus, a Palo Alto, Calif.-based startup that plans to offer next-generation data storage and analysis services, recently disclosed members of its management team and scientific advisory board on its website:

Andreas Sundquist is the company's co-founder and CEO. He holds a PhD in computer science from Stanford University and a master's as well as bachelor's degree in electrical engineering and computer science from the Massachusetts Institute of Technology.

Arend Sidow is a co-founder of DNAnexus. He is an associate professor of pathology and genetics at Stanford, as well as director of computation at the recently established Stanford Center for Genomics and Personalized Medicine.

Serafim Batzoglou, another company co-founder, is an associate professor of computer science at Stanford. His research focuses on computational methods for sequence analysis, particularly in whole-genome assembly and comparative genomics.

DNAnexus' scientific advisory board includes Jeff Heer, an assistant professor in the computer science department at Stanford; Rick Myers, director of the HudsonAlpha Institute for Biotechnology in Huntsville, Ala.; Gavin Sherlock, an assistant research professor in the department of genetics at the Stanford School of Medicine; and Mike Snyder, professor and chair of the department of genetics at Stanford and director of the Stanford Center for Genomics and Personalized Medicine.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.